1. Home
  2. BLRX vs FPAY Comparison

BLRX vs FPAY Comparison

Compare BLRX & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • FPAY
  • Stock Information
  • Founded
  • BLRX 2003
  • FPAY 2003
  • Country
  • BLRX Israel
  • FPAY United States
  • Employees
  • BLRX N/A
  • FPAY N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • BLRX Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • BLRX 17.2M
  • FPAY 18.3M
  • IPO Year
  • BLRX 2011
  • FPAY N/A
  • Fundamental
  • Price
  • BLRX $3.81
  • FPAY $0.78
  • Analyst Decision
  • BLRX Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • BLRX 2
  • FPAY 2
  • Target Price
  • BLRX $19.00
  • FPAY $3.25
  • AVG Volume (30 Days)
  • BLRX 32.7K
  • FPAY 186.0K
  • Earning Date
  • BLRX 08-14-2025
  • FPAY 11-12-2025
  • Dividend Yield
  • BLRX N/A
  • FPAY N/A
  • EPS Growth
  • BLRX N/A
  • FPAY N/A
  • EPS
  • BLRX N/A
  • FPAY N/A
  • Revenue
  • BLRX $17,251,000.00
  • FPAY $139,800,732.00
  • Revenue This Year
  • BLRX N/A
  • FPAY $19.71
  • Revenue Next Year
  • BLRX N/A
  • FPAY N/A
  • P/E Ratio
  • BLRX N/A
  • FPAY N/A
  • Revenue Growth
  • BLRX 1.19
  • FPAY 19.51
  • 52 Week Low
  • BLRX $2.30
  • FPAY $0.45
  • 52 Week High
  • BLRX $26.80
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 49.18
  • FPAY 52.74
  • Support Level
  • BLRX $3.68
  • FPAY $0.77
  • Resistance Level
  • BLRX $4.11
  • FPAY $0.98
  • Average True Range (ATR)
  • BLRX 0.24
  • FPAY 0.08
  • MACD
  • BLRX 0.02
  • FPAY 0.03
  • Stochastic Oscillator
  • BLRX 41.50
  • FPAY 46.38

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: